progesterone receptor negative
Showing 26 - 41 of 41
Estrogen Receptor Negative, HER2/Neu Negative, Metastatic Breast Cancer Trial in Seattle (Pembrolizumab, Cisplatin)
Withdrawn
- Estrogen Receptor Negative
- +5 more
- Pembrolizumab
- Cisplatin
-
Seattle, WashingtonSeattle Cancer Care Alliance, Fred Hutch/University of Washingto
Apr 24, 2019
B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)
Completed
- B-Cell Neoplasm
- +15 more
-
Stanford, CaliforniaStanford University Medical Center
Dec 11, 2018
Advanced Malignant Solid Tumor, Estrogen Receptor Negative, GPNMB Positive Trial (drug, biological, other)
Withdrawn
- Advanced Malignant Solid Neoplasm
- +17 more
- Glembatumumab Vedotin
- +4 more
- (no location specified)
Jul 17, 2018
Basal-Like Breast Carcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier Trial in United States (Laboratory Biomarker
Completed
- Basal-Like Breast Carcinoma
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +6 more
Jun 28, 2018
Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Houston (Dinaciclib, Epirubicin Hydrochloride,
Completed
- Estrogen Receptor Negative
- +6 more
- Dinaciclib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 29, 2018
Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Bronx, New York (Laboratory Biomarker Analysis,
Completed
- Estrogen Receptor Negative
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Bronx, New York
- +5 more
Dec 21, 2017
Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in New York, The Bronx (drug, procedure, other)
Terminated
- Estrogen Receptor Negative
- +13 more
- Akt Inhibitor MK2206
- +3 more
-
New York, New York
- +2 more
Aug 1, 2017
Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,
Withdrawn
- Estrogen Receptor Negative
- +22 more
- Laboratory Biomarker Analysis
- +2 more
- (no location specified)
Apr 20, 2017
Adult Solid Tumor, Estrogen Receptor Negative, Fallopian Tube Serous Tumor Trial (Hsp90 Inhibitor AT13387, Laboratory Biomarker
Withdrawn
- Adult Solid Neoplasm
- +12 more
- Hsp90 Inhibitor AT13387
- +3 more
- (no location specified)
Jul 22, 2016
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Boston (Laboratory Biomarker Analysis,
Completed
- Estrogen Receptor Negative
- +5 more
- Laboratory Biomarker Analysis
- Tivantinib
-
Boston, Massachusetts
- +1 more
Feb 23, 2016
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Columbus (drug, other, procedure)
Terminated
- Estrogen Receptor Negative
- +8 more
- Carboplatin
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 3, 2015
Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Positive Trial in United States (Akt Inhibitor MK2206,
Terminated
- Estrogen Receptor Negative
- +6 more
- Akt Inhibitor MK2206
- +4 more
-
New Haven, Connecticut
- +4 more
Aug 26, 2015
Adult Solid Tumor, Estrogen Receptor Negative, Estrogen Receptor Positive Trial in Hershey, Pittsburgh (Carboplatin, Laboratory
Completed
- Adult Solid Neoplasm
- +10 more
- Carboplatin
- +4 more
-
Hershey, Pennsylvania
- +2 more
May 22, 2015
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Baltimore, Ann Arbor, Detroit
Terminated
- Estrogen Receptor Negative
- +7 more
- Gamma-Secretase Inhibitor RO4929097
- +4 more
-
Baltimore, Maryland
- +2 more
Apr 14, 2015